| Literature DB >> 22661918 |
Tuulia Tynkkynen, Jaakko Mursu, Tarja Nurmi, Kari Tuppurainen, Reino Laatikainen, Pasi Soininen.
Abstract
A protocol for determination of oxidation susceptibility of serum lipids based on proton nuclear magnetic resonance ((1)H NMR) spectroscopy is presented and compared to the commonly used spectrophotometric method. Even though there are methodological differences between these two methods, the NMR-based oxidation susceptibility correlates well (r(2) = 0.73) with the lag time determined spectrophotometrically. In addition to the oxidizability of serum lipids, the NMR method provides also information about the lipid profile. The NMR oxidation assay was applied to the chocolate study including fasting serum samples (n = 45) from subjects who had consumed white (WC), dark (DC) or high-polyphenol chocolate (HPC) daily for 3 weeks. The oxidation susceptibility of serum lipids decreased in the HPC group, and there was a significant difference between the WC and HPC groups (P = 0.031). According to the random forest analysis, the consumption of the HPC chocolate induced changes to the amounts of HDL, phosphatidylcholine, sphingomyelin, and nervonic, docosahexaenoic and myristic acids. Furthermore, arachidonic, docosahexaenoic, docosapentaenoic and palmitic acids, gamma-glutamyl transferase, hemoglobin, HDL, phosphatidylcholine and choline containing phospholipids explained about 60% of the oxidation susceptibility values. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11306-011-0323-2) contains supplementary material, which is available to authorized users.Entities:
Year: 2011 PMID: 22661918 PMCID: PMC3351613 DOI: 10.1007/s11306-011-0323-2
Source DB: PubMed Journal: Metabolomics ISSN: 1573-3882 Impact factor: 4.290
Fig. 1A 1H NMR spectrum of extracted serum with signal assignments (a). Some essential parts of the spectra (b–e) before and after the oxidation are shown at the top of the figure. The signals arising from the double bond protons (b) and the bisallylic protons from PUFAs (c) decrease during oxidation. There are also changes in the amounts of different fatty acids (d). Cholesterol oxidizes slightly under the conditions used and these oxysterol C(18)H3 signals resonate at 0.61–0.69 ppm. The signal areas are referenced to total cholesterol C(18)H3 signals including also the oxidized forms (e). EC esterified cholesterol, FA fatty acid, FC free cholesterol, PC phosphatidylcholine, PG phosphoglyceride, sat saturated, TC total cholesterol, TG triglyceride
Fig. 2The amounts of oxidized PUFAs during the copper induced oxidation with four different copper concentrations (a) and with a copper concentration of 0.5 mM for three subjects (b). Each data point in b is a mean of five determinations measured within period of 2 months
The NMR oxidation susceptibility (%) and the lag time (min) before (baseline) and after (change) the consumption of study chocolates for 3 weeks
| Parameter | WC | DC | HPC |
| |||
|---|---|---|---|---|---|---|---|
| Baseline | Change | Baseline | Change | Baseline | Change | ||
| Susceptibility | 72 ± 14 | 0 ± 5b | 71 ± 10 | −2 ± 8b | 64 ± 17 | −7 ± 10b | 0.033 |
| Lag timea | 118 ± 43 | 6 ± 31c | 122 ± 35 | 4 ± 32c | 160 ± 61 | −3 ± 28c | 0.711 |
Data expressed as means ± SD; P for the differences in changes between the groups (one-way ANOVA); WC white chocolate, DC dark chocolate, HPC high-polyphenol chocolate
aThe values of this assay were determined previously (Mursu et al. 2004)
b n = 15
c n = 14
Fig. 3The amounts of oxidized PUFAs after the copper induced oxidation determined by the 1H NMR method plotted against the corresponding lag time values of the oxidation monitored spectrophotometrically from the chocolate study samples. The regression line is y = −0.2665x + 100.4, r 2 = 0.7308
The variables included into the RF analyses
| Number | Variable |
|---|---|
| 1 | Hemoglobin (g/l) |
| 2 | Hematocrit |
| 3 | Erythrocytes (×1012/l) |
| 4 | Leucocytes (×109/l) |
| 5 | MCV (fl) |
| 6 | Thrombocytes (×109/l) |
| 7 | Total serum cholesterol (mmol/l)a |
| 8 | LDL-cholesterol (mmol/l)b |
| 9 | HDL-cholesterol (mmol/l)c |
| 10 | Serum TGs (mmol/l)a |
| 11 | Creatinine (μmol/l)d |
| 12 | ASAT (U/l)d |
| 13 | ALAT (U/l)d |
| 14 | B-glucose (mmol/l) |
| 15 | γ-GT (U/l)d |
| 16 | Myristic acid, 14:0 (%)e |
| 17 | Palmitic acid, 16:0 (%)e |
| 18 | Palmitoleic acid, 16:1 (%)e |
| 19 | Stearic acid, 18:0 (%)e |
| 20 | Oleic acid, 18:1 (%)e |
| 21 | Linoleic acid, 18:2 (%)e |
| 22 | α-linolenic acid, 18:3ω-3 (%)e |
| 23 | Arachidonic acid, 20:4ω-6 (%)e |
| 24 | Eicosatetraenoic acid, 20:4ω-3 (%)e |
| 25 | Eicosapentaenoic acid, 20:5 (%)e |
| 26 | γ-linolenic acid, 18:3ω-6 (%)e |
| 27 | Docosahexaenoic acid, 22:6 (%)e |
| 28 | Docosapentaenoic acid, 22:5 (%)e |
| 29 | Behenic acid, 22:0 (%)e |
| 30 | Lignoceric acid, 24:0 (%)e |
| 31 | Nervonic acid, 24:1 (%)e |
| 32 | Retinol (μg)f |
| 33 | Carotene (μg)f |
| 34 | Vitamin D (μg)f |
| 35 | Vitamin E (mg)f |
| 36 | Thiamine B1 (mg)f |
| 37 | Riboflavin B2 (mg)f |
| 38 | Niacin B3 (mg)f |
| 39 | Pyridoxine B6 (mg)f |
| 40 | Cobalamin B12 (μg)f |
| 41 | Folate B9 (μg)f |
| 42 | Pantothenic acid B5 (mg)f |
| 43 | Biotin B7 (μg)f |
| 44 | Vitamin C (mg)f |
| 45 | Calcium (mg)f |
| 46 | Magnesium (mg)f |
| 47 | Iron (mg)f |
| 48 | Selenium (μg)f |
| 49 | Mercury (μg)f |
| 50 | Flavonoids (mg)f |
| 51 | Quercetin (mg)f |
| 52 | Myricetin (mg)f |
| 53 | Kaempferol (mg)f |
| 54 | Alcohol (E%)f |
| 55 | Total serum cholesterol (mmol/l) |
| 56 | Esterified cholesterol (mmol/l) |
| 57 | Free cholesterol (mmol/l) |
| 58 | Total FAs (mmol/l) |
| 59 | 18:2 (%) |
| 60 | Other PUFAs than 18:2 (mmol/l) |
| 61 | All PUFAs (mmol/l) |
| 62 | 22:6 (%) |
| 63 | Total TG (mmol/l) |
| 64 | Total PG (mmol/l) |
| 65 | Phosphatidylcholine (mmol/l) |
| 66 | Sphingomyelin (mmol/l) |
| 67 | Total choline phospholipids (mmol/l) |
| 68 | ω-3 FAs (%) |
| 69 | ω-6 and ω-7 FAs (%) |
| 70 | ω-9 and saturated FAs (%) |
| 71 | Ratio of CH2 signal area to FA signal area |
| 72 | Ratio of TG to PG |
| 73 | Ratio of CH2 signal area to DB signal area |
| 74 | Ratio of DB signal area to FA signal area |
| 75 | Ratio of PUFAs to DB signal area |
| 76 | Ratio of PUFAs to FA |
| 77 | Average FA chain length |
The variables 1–54 were determined previously (Mursu et al. 2004) whereas the variables 55–77 were obtained from 1H NMR spectrum and were scaled so that the total serum cholesterol values determined both in the previous study (variable 7) and by the 1H NMR method (variable 55) are identical. The baseline and end-point values (VARBASE+END) or the change (VARCHANGE) values of these variables were used depending on the RF analysis
ALAT alanine transaminase, ASAT aspartate transaminase, DB double bond, FA fatty acid, MCV mean cell volume, PG phosphoglyceride, PUFA polyunsaturated fatty acid, TG triglyceride, γ-GT, gamma-glutamyl transferase
aDetermined using an enzymatic colorimetric test
bDetermined by a direct cholesterol measurement (Konelab)
cMeasured from the supernatant after magnesium chloride dextran sulphate precipitation
dMeasured using a Clinical Chemistry Analyzer (Konelab)
eSerum fatty acids were extracted using chloroform–methanol and methylated with sulphuric acid–methanol. The methylated fatty acids were analyzed by a gas chromatograph
fBased on the 4 day food record that was collected before the intervention and during the last week of the supplementation period
Fig. 4RF clustering of the chocolate study samples [WC (W), DC (D) and HPC (P) groups] with the change variables shown in Table 2 excluding behenic acid. The clustering was obtained with six variables and the variable importance measures, mean decrease in accuracy and mean decrease in Gini index, are shown for each of these variables. 24:1 nervonic acid; 22:6 docosahexaenoic acid, PC phosphatidylcholine, SM sphingomyelin, 14:0 myristic acid
Fig. 5The profiles of the variable changes for the WC (white), DC (light grey), and HPC (dark grey) groups. The values are expressed as standard deviation units from the mean of the whole study population. 24:1 nervonic acid, 22:6 docosahexaenoic acid, PC phosphatidylcholine, SM sphingomyelin, 14:0 myristic acid
Fig. 6The correlations between the variables (VARBASE+END) (shown in Table 2) and the NMR oxidation susceptibility (NMROXBASE+END) values (black) and the lag time (LAGBASE+END) values (grey). Since the NMR oxidation susceptibility values and the lag time values are inversely correlated, the inverse correlation coefficients for the spectrophotometric method are presented in order to ease the comparison. P-values are indicated with one (0.001 < P ≤ 0.05) or two (P ≤ 0.001) asterisks
Fig. 7Average variable importances for the variables shown in Table 2. The numbering on the x-axis follows the numbering of the variables in Table 2
Fig. 8Increase in mean square error (IncMSE) (%) and increase in node purity (Inc node purity) values for each variable obtained from the RF regression when modeling the oxidation susceptibility values (NMROXBASE+END explained with VARBASE+END) and the lag time values (LAGBASE+END explained with VARBASE+END). 16:0 palmitic acid, 20:4 ω-6 arachidonic acid, 22:5 docosapentaenoic acid, 22:6 docosahexaenoic acid, HB hemoglobin, PC phosphatidylcholine, tot chol total choline phospholipids